Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALXO
CUE
Add up to 3 more stocks
ALXO
ALX Oncology Holdings Inc.
-7.44%
$1.12-0.09Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$150.71M
52W Range
$1.05 - $2.66
CUE
Cue Biopharma, Inc.
-1.99%
$23.88-0.48Delayed quote: Oct 6, 2026, 1:13 PM EDT
Market Cap
$173.44M
52W Range
$4.97 - $45.50
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.11 | 75.08 |
| P/S Ratio | N/A | 4.61 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 99.7% |
| Operating Margin | 0.0% | -96.6% |
| Net Margin | 0.0% | -435.8% |
| ROE | -59.4% | -7104.2% |
| ROA | -50.3% | -534.4% |
| ROIC | -56.5% | -1039.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.71 | 1.25 |
| Quick Ratio | 9.71 | 1.25 |
| Debt/Equity | 0.07 | 3.81 |
| Interest Coverage | -64.93 | -74.29 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.